State Ledger
Company profile

NANOVIRICIDES, INC. CIK 1379006

Ticker
NNVC (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
Shelton, CT 06484
Fiscal year end
2025 (FY)
Market Data
Close
$1.31
Change
-$0.01
Change %
-0.38%
Volume
2,376

NNVC · trading date Oct 9, 2026 · previous close $1.31 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$9.47M
Total assets
$8.82M
Total liabilities
$1.30M
Stockholders' equity
$7.52M
Cash & equivalents
$1.56M
Operating income
-$9.59M
Operating cash flow
-$8.48M
Capital expenditures
$57.0K

Fiscal year 2025, via 10-K filed 2025-09-29. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$8.54M
Free cash flow margin
—
Liabilities / assets
14.7%
Equity / assets
85.2%
CapEx / revenue
—
Operating cash flow / net income
0.90×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$9.47M $8.82M $1.30M $7.52M
2024 — -$8.29M $12.82M $1.36M $11.46M
2023 — -$8.59M $16.90M $2.03M $14.87M
2022 — -$8.11M $23.49M $412.8K $23.08M
2021 — -$8.82M $30.26M — $29.91M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 424B3
2026-09-03
Financials filed via
Form 10-K
filed 2025-09-29

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Shelton, CT 06484
1 CONTROLS DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:22 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Connecticut — Public Companies